78 related articles for article (PubMed ID: 9270879)
1. Intracellular distribution of phospholipase C gamma 1 in cell lines with different levels of transformation.
Diakonova M; Chilov D; Arnaoutov A; Alexeyev V; Nikolsky N; Medvedeva N
Eur J Cell Biol; 1997 Aug; 73(4):360-7. PubMed ID: 9270879
[TBL] [Abstract][Full Text] [Related]
2. The intranuclear amount of phospholipase C beta 1 decreases following cell differentiation in Friend cells, whereas gamma 1 isoform is not affected.
Zini N; Ognibene A; Marmiroli S; Bavelloni A; Maltarello MC; Faenza I; Valmori A; Maraldi NM
Eur J Cell Biol; 1995 Sep; 68(1):25-34. PubMed ID: 8549587
[TBL] [Abstract][Full Text] [Related]
3. Expression of phospholipase C isozymes by murine B lymphocytes.
Hempel WM; DeFranco AL
J Immunol; 1991 Jun; 146(11):3713-20. PubMed ID: 2033248
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of phospholipase C-gamma1 in rat 3Y1 fibroblast cells leads to malignant transformation.
Chang JS; Noh DY; Park IA; Kim MJ; Song H; Ryu SH; Suh PG
Cancer Res; 1997 Dec; 57(24):5465-8. PubMed ID: 9407951
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical localization of phospholipase C-gamma in rat embryo fibroblasts.
McBride K; Rhee SG; Jaken S
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7111-5. PubMed ID: 1651494
[TBL] [Abstract][Full Text] [Related]
6. Detection of phosphatidylcholine-specific phospholipase C in NIH-3T3 fibroblasts and their H-ras transformants: NMR and immunochemical studies.
Podo F; Ferretti A; Knijn A; Zhang P; Ramoni C; Barletta B; Pini C; Baccarini S; Pulciani S
Anticancer Res; 1996; 16(3B):1399-412. PubMed ID: 8694508
[TBL] [Abstract][Full Text] [Related]
7. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
Strassheim D; Shafer SH; Phelps SH; Williams CL
Cancer Res; 2000 May; 60(10):2730-6. PubMed ID: 10825148
[TBL] [Abstract][Full Text] [Related]
8. Expression of a 118 Kd protein in colon carcinoma cells that is immunologically related to PLC-gamma 1 and is augmented by serum-free conditions.
Fry DW; Ambroso LA
Cancer Biochem Biophys; 1993 Sep; 13(4):265-78. PubMed ID: 8521376
[TBL] [Abstract][Full Text] [Related]
9. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.
Kassis J; Moellinger J; Lo H; Greenberg NM; Kim HG; Wells A
Clin Cancer Res; 1999 Aug; 5(8):2251-60. PubMed ID: 10473113
[TBL] [Abstract][Full Text] [Related]
10. Monocytic differentiation of HL-60 cells is characterized by the nuclear translocation of phosphatidylinositol 3-kinase and of definite phosphatidylinositol-specific phospholipase C isoforms.
Neri LM; Marchisio M; Colamussi ML; Bertagnolo V
Biochem Biophys Res Commun; 1999 Jun; 259(2):314-20. PubMed ID: 10362505
[TBL] [Abstract][Full Text] [Related]
11. Immunofluorescent detection of actin cytoskeleton in spontaneously transformed and B77-supertransformed cells using antibody to tropomyosin.
Urbancíková M; Grófová M
Neoplasma; 1990; 37(6):703-10. PubMed ID: 2177151
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of oxidant-induced nuclear factor-kappaB activation and inhibitory-kappaBalpha degradation and instability of F-actin cytoskeletal dynamics and barrier function by epidermal growth factor: key role of phospholipase-gamma isoform.
Banan A; Zhang LJ; Shaikh M; Fields JZ; Farhadi A; Keshavarzian A
J Pharmacol Exp Ther; 2004 Apr; 309(1):356-68. PubMed ID: 14724221
[TBL] [Abstract][Full Text] [Related]
13. Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting.
Falasca M; Logan SK; Lehto VP; Baccante G; Lemmon MA; Schlessinger J
EMBO J; 1998 Jan; 17(2):414-22. PubMed ID: 9430633
[TBL] [Abstract][Full Text] [Related]
14. v-Src accelerates spontaneous motility via phosphoinositide 3-kinase, phospholipase C and phospholipase D, but abrogates chemotaxis in Rat-1 and MDCK cells.
Platek A; Mettlen M; Camby I; Kiss R; Amyere M; Courtoy PJ
J Cell Sci; 2004 Sep; 117(Pt 20):4849-61. PubMed ID: 15340010
[TBL] [Abstract][Full Text] [Related]
15. Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cells.
Matteucci A; Faenza I; Gilmour RS; Manzoli L; Billi AM; Peruzzi D; Bavelloni A; Rhee SG; Cocco L
Cancer Res; 1998 Nov; 58(22):5057-60. PubMed ID: 9823310
[TBL] [Abstract][Full Text] [Related]
16. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.
Saucier C; Papavasiliou V; Palazzo A; Naujokas MA; Kremer R; Park M
Oncogene; 2002 Mar; 21(12):1800-11. PubMed ID: 11896612
[TBL] [Abstract][Full Text] [Related]
17. Altered distribution of phospholipase C-gamma 1 in benign hyperproliferative epidermal diseases.
Nanney LB; Gates RE; Todderud G; King LE; Carpenter G
Cell Growth Differ; 1992 Apr; 3(4):233-9. PubMed ID: 1515369
[TBL] [Abstract][Full Text] [Related]
18. Suppression of phospholipase C beta, gamma, and delta families alters cell growth and phosphatidylinositol 4,5-bisphosphate levels.
Nebigil CG
Biochemistry; 1997 Dec; 36(50):15949-58. PubMed ID: 9398329
[TBL] [Abstract][Full Text] [Related]
19. Suppression of epidermal growth factor-induced phospholipase C activation associated with actin rearrangement in rat hepatocytes in primary culture.
Nojiri S; Hoek JB
Hepatology; 2000 Nov; 32(5):947-57. PubMed ID: 11050044
[TBL] [Abstract][Full Text] [Related]
20. CAIR-1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-gamma and Hsp70/Hsc70.
Doong H; Price J; Kim YS; Gasbarre C; Probst J; Liotta LA; Blanchette J; Rizzo K; Kohn E
Oncogene; 2000 Sep; 19(38):4385-95. PubMed ID: 10980614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
